Miami, Mar 17: Cancer treatment is often described as a race against time. But for many patients, chemotherapy-induced thrombocytopenia (CIT) creates a roadblock—forcing clinicians to delay or reduce treatment. A new phase 3 clinical trial published in The New England Journal of Medicine suggests there may now be a way to keep that journey moving forward. In the international RECITE trial, investigators found that romiplostim, a…
Spring travel: physicians urge travelers to understand their DVT risks on trips longer than four hours
Expert tips for recognizing symptoms and reducing blood clot risk during extended sitting GREENBELT, Md. — With spring travel ramping up, Center for Vein Restoration (CVR) is reminding the public that anyone traveling more than four hours by air, car, bus or train can be at risk for potentially deadly blood clots, particularly people with additional risk factors. The CDC notes that venous thromboembolism (VTE), which includes…
This Tiny Cellular Portal Could Open Vast Possibilities for Medicine
Inside each of your cells, there lies the nucleus, its master command center. Protected inside each nucleus are your chromosomes, containing all the genetic instructions for making proteins. To keep the body operating smoothly, proteins, RNA molecules, and molecular signals must constantly flow in and out of this cellular HQ, mediating which genetic instructions are used when. Nearly all of that two-way traffic passes through…
Dhriya Goes Home Fit and Well After the Youngest Donor Gifts Her a New Lease of Life
Thiruvananthapuram March 16: Six month old Dhriya returns home safe and well, after having overcome the life-threatening liver disease she was born with. She received a new lease of life through a liver transplant at KIMSHEALTH, with Alin becoming the youngest organ donor in the country. Dhriya was diagnosed with biliary atresia, a condition characterised by a blockage in the ducts that carry bile from…
Nit Happens, A New Clinically Proven Non-Toxic Lice Treatment Now Available at Walgreens
The gentle and highly effective lice treatment is available at 6,000 Walgreens locations in the United States DALLAS, TX (Mar16)- Cartwheel, a healthcare brand developed by moms for moms, is today announcing the availability of its inaugural consumer product, Nit Happens, at 6,000 Walgreens locations in the United States. The over-the-counter lice treatment uses only non-toxic, naturally-derived ingredients to eliminate lice and nits, avoiding…
Children’s Hospital Los Angeles Expert Highlights Five Commonly Overlooked Pediatric Lipid Disorders
Lipid abnormalities are increasingly being detected in children, largely due to the rising prevalence of obesity and diabetes as well as earlier screening practices. However, pediatric lipid disorders differ significantly from those seen in adults, and if left untreated, they can increase the risk of cardiovascular diseases such as heart attacks later in life. At Children’s Hospital Los Angeles, children with abnormal lipid levels…
9 Essential Ways to Evaluate a Reliable Health Insurer in 2026
Pic Credit: Pexel Selecting the right health insurer is one of the most important decisions you can make for your family’s well-being. With healthcare costs rising and insurance options expanding, it’s crucial to choose a provider that offers reliable coverage, excellent support, and smooth access to medical care. In 2026, several real-world factors can help you assess which health insurer is truly trustworthy. 1. Check…
Growing Implants Bring New Hope to Children with Bone Cancer
Pic Credit: Pexel A new medical innovation called the “growing implant” is transforming the treatment of bone cancer in children. The technique allows surgeons to remove cancer-affected bone while preserving the limb and enabling it to grow normally, improving long-term mobility and quality of life. Bone cancers such as osteosarcoma and Ewing sarcoma often affect children and adolescents. Traditional treatments sometimes required amputating the limb or…
FDA-Approved Cancer Drug Fedratinib Reshapes How Cell Organelles Communicate, Providing New Therapeutic Avenues
Researchers at the University of Michigan have discovered that the FDA-approved drug Fedratinib may promote communication between two critical cellular organelles—the endoplasmic reticulum and mitochondria—offering new insights into cellular metabolism and potential therapeutic strategies for multiple diseases. Cells function much like complex cities, with different organelles performing specialized roles. Mitochondria generate energy, the endoplasmic reticulum acts as a transport network, and lysosomes manage waste disposal.…
Researchers break decades-old bottleneck in chemotherapy drug manufacturing
Researchers break decades-old bottleneck in chemotherapy drug manufacturing An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent. The study identifies and resolves molecular “bottlenecks” that have limited the natural production of this drug for over 50 years. Doxorubicin is a chemotherapy drug that was first approved for medical use in the 1970s. It is a cornerstone in…
